Search

everythinglearnresearchcommunity

for

Search:↓

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

The risks of testosterone implants in women outweigh the benefits.

New genes and pathways are important for testosterone production and male sexual development.

Using finasteride with TIP extends time off period for prostate cancer patients.

Fenugreek extract may help treat benign prostatic hyperplasia.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.

DHT deficiency in rats reduces sperm content and affects testis structure over time.

Finasteride causes temporary cell death in BPH tissues.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

A new compound was effective for imaging prostate cancer in rats.

Testosterone increases hair follicle cell growth when beard or axillary skin cells are present together.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Telocytes help organize male reproductive tissues and their changes can lead to diseases.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Finasteride significantly reduces the risk of prostate cancer.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.